• Hey, guest user. Hope you're enjoying NeoGAF! Have you considered registering for an account? Come join us and add your take to the daily discourse.

Kodak inside trading

CloudNull

Banned
Kodak(camera company) secured a massive loan to start making Pharmaceuticals in the US. The company's stocked sky rocketed and people are saying that their is some inside trading going on.

Why would a camera company transition to making Pharmaceuticals? I am all for manufacturing coming back to the States but the logistics to this seem unusual. Anyone have deeper knowledge on this that the MSM is missing?

 

haxan7

Banned
They are making a direct pro-Trump, anti-China move by doing this. It's makes sense that outside forces would come in and try to crush them. Bet you the insider trading stuff is made up.

I imagine producing film involves heavy use of chemicals so making drugs is probably not as great a switch as it sounds.
 
Last edited:
Kodak(camera company) secured a massive loan to start making Pharmaceuticals in the US. The company's stocked sky rocketed and people are saying that their is some inside trading going on.

Why would a camera company transition to making Pharmaceuticals? I am all for manufacturing coming back to the States but the logistics to this seem unusual. Anyone have deeper knowledge on this that the MSM is missing?

This happens all the time, it's just normally at the parent company level instead of reusing a brand name. Single brands with huge diversity are common in Japan, though.
 

CloudNull

Banned
This happens all the time, it's just normally at the parent company level instead of reusing a brand name. Single brands with huge diversity are common in Japan, though.

The article does state that the camera company in Japan Fujifilm is doing the same. I didn't think of it from the chemical perspective.
 

CloudNull

Banned
Korea as well, there are pharmaceutical companies with TV and movie production arms. Samsung has a pharmaceutical arm.

...And this is why I come to Gaf. The media and twitter are trying to paint this as a massive black mark on the current admin. Thank you for the logical responses that seem to get buried by all the reeeeeeeeeeeeeeing.

I hope more companies get involved in bring production back to the states.
 

Amory

Member
I work in pharmaceutical MFG, and used to work with a guy who worked for Polaroid in MFG directly before he was hired by my company.

At the end of the day you're manipulating valves and connecting hoses to tanks and working with chemicals.

Now, obviously you need to hire a whole new set of people who have experience in pharmaceuticals, and you're going to have to comply with a much more rigid set of regulations. But this isn't that farfetched.

Edit: I can't speak to the insider trading aspect of the story, though. No idea about any of that.
 
Last edited:

oagboghi2

Member
Shit I had no idea Kodak was making a move like this. Their stock was under 3 dollar a few days ago and it just peaked at a little above 50 a few hours.

That was a missed opportunity. Fuck
 
Last edited:

DKehoe

Gold Member
Is that not typical for something like this? A lot of people (relatively speaking) are going to know at least something about big deal like this. If people can then make money from that knowledge then they will. Not saying it's right, just not surprising.

Edit: damn

 
Last edited:

haxan7

Banned
Is that not typical for something like this? A lot of people (relatively speaking) are going to know at least something about big deal like this. If people can then make money from that knowledge then they will. Not saying it's right, just not surprising.

Edit: damn


it's up about 350%-400% from 2 days ago
 

rykomatsu

Member
Why would a camera company transition to making Pharmaceuticals? I am all for manufacturing coming back to the States but the logistics to this seem unusual. Anyone have deeper knowledge on this that the MSM is missing?

I imagine producing film involves heavy use of chemicals so making drugs is probably not as great a switch as it sounds.

Winner, winner, chicken dinner.

At the end of the day film requires commercial level production of chemicals, so there's a fine chemicals engineering component to companies that produce film and the chemicals needed to develop film.

Controls and protocols need to be put into place to make this successful, but it's not a huge jump. FDA compliance from a systems and data mangement perspective, they'd also be creating a generic, so they'd need to implement and carry out protocols to demonstrate bioequivalency to the brand name HCQ, and also implement various other tests for release.

The hurdle for generics is quite low compared to novel pharmaceuticals. Since film chemistry has gone down in demand, I'm guessing Kodak has a lot of capacity to transition, whereas existing pharma probably has their pipeline full with current production. This is a good win for Kodak if the demand for HCQ is high.
 

rykomatsu

Member
Also, just an FYI, Fujifilm (Kodak competitor) manufactures Avigan, which is also a COVID-19 treatment in other parts of the world. So again, not far fetched.
 

GloveSlap

Member
The insider trading bit is about how the volume of shares and call options rose sharply in the days leading up to the announcement, which is absolutely true. SEC needs to crack down on this garbage.
 

StreetsofBeige

Gold Member
Missed out on a scam momo run.

Stock went from $2.50 to $60 in two days. Closed at $33. Some people are already down 50%.

Like most yo-yo runs, you'll probably get a few upsticks back to $40, and the it'll sink to $10.
 

Hinedorf

Banned
Kodak has been in medical (medical imaging) for a long time running, doesn't seem that hard to believe, neither does the insider trading
 


If you go to the bottom of the page you can see recent insider transactions. They have a certain number of days before they have to fill out the report, so it's possible there are more people that bought but they haven't reported yet.


The executive chairman in particular Continenza James bought 46 thousand shares at 2.22 on June 23rd. There were a few others, but you won't be able to see most of the insider trading transactions that would have happened in the last week for a few more weeks, assuming they report these transactions correctly.


Insider trading is a hobby horse of mine. It was theorized in a stock trading book that I read that if you learned to examine insider transactions you could make consistently profitable trades. I spend a lot of time looking at insider transactions and studying them. I look forward to seeing what trades are reported a month from now.
 

V2Tommy

Member
I heard rumblings of this late Monday night early Tues, but lacked the conviction to lay some dollars on the line.

This might be the biggest hands slipped through the fingers I’ve ever done.

Don't be so hard on yourself. I mean, sure, you could've become rich in 3 days. If you were psychic. It's hard being a responsible and putting down big bucks on some rumblings you heard.
 

Mistake

Member
Spectrum did my lab results for some moles, and they’re a cable company. You’d be surprised how many offshoots businesses have
 

StreetsofBeige

Gold Member
I heard rumblings of this late Monday night early Tues, but lacked the conviction to lay some dollars on the line.

This might be the biggest hands slipped through the fingers I’ve ever done.
There was some weird shit going on Monday, so some people knew.

The stock was around $2.00 for ages and suddenly spiked to $2.50 on trading volume of around 1.5 million shares when it usually only trades maybe 100,000 shares.

Then on Tuesday all hell broke loose going to $60 and almost 300 million shares traded.
 
D

Deleted member 1159

Unconfirmed Member
I imagine producing film involves heavy use of chemicals so making drugs is probably not as great a switch as it sounds.

Regulatory Affairs and Quality Assurance pro with background in pharma and med devices here. It’s a big switch. There’s nothing trivial about implementing risk management and quality systems, especially with pharmaceuticals.

Throw enough money at it and a company like Kodak can pull it off I’m sure, but it’s by no means in their wheelhouse because they use chemicals in making film. I’m sure Nintendo makes colorant changes for their plastics all the time and don’t give two shits about biocompatibility. In pharma and med devices that’s months of evaluations and testing, possible submissions to regulatory bodies, etc. I doubt Kodak has any infrastructure in place for any of that. But if they’re hiring...
 
Last edited by a moderator:

Gp1

Member
I imagine producing film involves heavy use of chemicals so making drugs is probably not as great a switch as it sounds.

Exactly this. They already produce farmaceutical ingredients / raw materials for quite some time
 
Last edited:
D

Deleted member 1159

Unconfirmed Member
Exactly this. They already produce farmaceutical ingredients / raw materials for quite some time

Receipts? Do you understand the scrutiny regulatory bodies put materials under when they enter the body? With the new MDR regs in the EU and FDA’s stance on any sort of formulation changes in the US, any kind of manufacturing change or supplier change becomes a complete pain in the ass. The idea that “well Kodak makes chemicals I guess...“ is about as plausible as Exxon making drugs because they do chemicals too
 

Gp1

Member
Receipts? Do you understand the scrutiny regulatory bodies put materials under when they enter the body? With the new MDR regs in the EU and FDA’s stance on any sort of formulation changes in the US, any kind of manufacturing change or supplier change becomes a complete pain in the ass. The idea that “well Kodak makes chemicals I guess...“ is about as plausible as Exxon making drugs because they do chemicals too

I think i expressed myself poorly at the other post.
They already have some know how at it. Kodak already began to make starting materials / raw materials / drug ingredients four years ago. What they are doing now is expanding their operations at its New York and Minnesota facilities.

It's not a complete unaligned business to them.

ps. As a matter of facts i've worked quite some time with business/regulatory affairs for a big pharmaceutical company. Not in US, but still...
 
Last edited:
Top Bottom